Keyphrases
Brugada Syndrome
100%
Congenital Long QT Syndrome
68%
Disease Manifestations
39%
Syndrome Diagnosis
36%
National Cohort Study
34%
Disease Risk
33%
Torsades Des Pointes
33%
Pregnancy-associated Plasma protein-A (PAPP-A)
33%
Arrhythmia
27%
Odds Ratio
25%
Syncope
25%
Confidence Interval
21%
Heparin
20%
Non-pregnant Women
20%
Proband
20%
Hazard Ratio
20%
Implantable Defibrillator
20%
Acute Coronary Syndrome
19%
Pharmacotherapy
18%
Psychiatric Comorbidity
16%
Beta-blockers
16%
Immigrants
16%
Depression Risk
16%
Neurological Comorbidities
16%
Anxiety-depression
16%
New Onset
16%
Diabetes Burden
16%
Mortality Risk
16%
Troponin Elevation
16%
Long-term Cardiovascular Outcomes
16%
Return of Spontaneous Circulation
16%
Cardiac Resynchronization Therapy
16%
Out-of-hospital Cardiac Arrest
16%
Non-migrants
16%
Pregnant Women
16%
Shockable Rhythm
16%
Bruce Protocol
16%
Diabetes Comorbidities
16%
Ethnic Differences
16%
Inappropriate Shock
16%
Long QT Syndrome
16%
Genotype
16%
Vulnerable Plaque
16%
Acute Coronary Event
16%
Genotype-phenotype Correlation
16%
Exercise Stress Test
16%
Hs-cTnT
16%
Young Patients
16%
Exercise Test
16%
SCN5A
16%
Medicine and Dentistry
Brugada Syndrome
83%
Disease
36%
Cohort Analysis
34%
Congenital Long-QT Syndrome
34%
Implantable Automatic Defibrillator
20%
Faintness
19%
Pediatrics
18%
Odds Ratio
18%
Pregnancy-Associated Plasma Protein A
16%
Exercise Test
16%
Heparin
16%
Return of Spontaneous Circulation
16%
Out of Hospital Cardiac Arrest
16%
Torsade Des Pointes
16%
Long QT Syndrome
16%
Catecholaminergic Polymorphic Ventricular Tachycardia
16%
Rhythm
16%
Diabetes
16%
Shock (Circulatory)
16%
Electrocardiogram
14%
Heart Arrest
12%
Drug Use
11%
Cardiac Dysrhythmia
10%
Adolescent
10%
Family History of Sudden Cardiac Death
9%
All Cause Mortality
8%
Hazard Ratio
8%
Prevalence
6%
Population Dynamics
6%
Proportional Hazards Model
6%
Ventricular Tachycardia
6%
Drug Therapy
5%
